Bats, pigs, and pangolins – oh my! The COVID-19 pandemic highlighted the consequences of viral spillover from animals, but it is not the first time in history that an animal virus has spurred disease in humans.
Scientists engineer the photosynthetic bacteria spirulina to produce biologics at a large enough scale to treat some of the world’s deadliest and most prevalent diseases.
Small antibodies called nanobodies produced in camels, llamas, and alpacas might help stop the spread of COVID-19, but can they stand up against the competition?
Mass photometry helps researchers investigate the large and dynamic molecular assemblies that drive HIV integration and influence antiviral drug development.